Glycogen Storage Disease Type V (McArdle's Disease) Summary

240 relevant articles (13 outcomes, 26 trials/studies) found for this Disease

Key Drugs and Agents for Glycogen Storage Disease Type V

1. Glucagon (Glukagon) : 3 outcomes 1 study in 4 results : FDA 4
   
2. Muscle Form Glycogen Phosphorylase (Myophosphorylase) : 2 outcomes 6 studies in 113 results : IBA
   
3. Glucose (Dextrose) : 2 outcomes 1 study in 16 results : FDA 183 Generic
   
4. Adenosine Triphosphate (ATP) : 2 outcomes in 7 results : IBA
   
5. Creatine : 1 outcome 3 studies in 6 results : IBA
   
6. Ribose (D-Ribose) : 1 outcome 1 study in 3 results : IBA
   
7. Verapamil (Calan) : 1 outcome 1 study in 2 results : FDA 7 Generic
   
8. Ramipril (Altace) : 1 outcome 1 study in 1 result : FDA 9 Generic
   
9. AMP Deaminase (Myoadenylate Deaminase) : 1 outcome in 6 results : IBA
   
10. Pyruvic Acid (Pyruvate) : 1 outcome in 1 result : IBA
    

Diseases Related to Glycogen Storage Disease Type V

1. Mitochondrial Myopathies (Mitochondrial Myopathy)
2. Glycogen Storage Disease Type VII (Tarui's Disease)
3. Muscular Diseases (Myopathy)
4. Myoglobinuria
5. Muscle Cramp (Cramp)

Key Therapies for Glycogen Storage Disease Type V

1. Exercise (Aerobic Exercise) : 1 outcome 1 study in 1 result
   
2. Cesarean Section (Caesarean Section) : 3 results
   
3. Microelectrodes : 2 results
   
4. Investigational Therapies (Experimental Therapy) : 1 result
   
5. Lasers (Laser) : 1 result